Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 785739, 11 pages
http://dx.doi.org/10.1155/2012/785739
Research Article

A Limited Role of p53 on the Ability of a Hexane Fraction of American Ginseng to Suppress Mouse Colitis

1Department of Pharmaceutical and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina and Medical University of South Carolina, Columbia, SC 29208, USA
2Institute for National Measurement Standards, National Research Council, Ottawa, ON, Canada K1A 0R6
3Department of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA
4Department of Cell and Molecular Pharmacology & Experimental Therapeutics and Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29245, USA
5School of Medicine, University of South Carolina, Columbia, SC 29208, USA

Received 22 March 2012; Revised 25 May 2012; Accepted 11 June 2012

Academic Editor: Paul W. Doetsch

Copyright © 2012 Deepak Poudyal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. L. Maynard and C. T. Weaver, “Intestinal effector T cells in health and disease,” Immunity, vol. 31, no. 3, pp. 389–400, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Eri, M. A. McGuckin, and R. Wadley, “T cell transfer model of colitis: a great tool to assess the contribution of T cells in chronic intestinal inflammation,” Methods in Molecular Biology, vol. 844, pp. 261–275, 2012. View at Publisher · View at Google Scholar
  3. R. H. Siggers and D. J. Hackam, “The role of innate immune-stimulated epithelial apoptosis during gastrointestinal inflammatory diseases,” Cellular and Molecular Life Sciences, vol. 68, no. 22, pp. 3623–3634, 2011. View at Publisher · View at Google Scholar
  4. Y. Jin, A. B. Hofseth, X. Cui et al., “American ginseng suppresses colitis through p53-mediated apoptosis of inflammatory cells,” Cancer Prevention Research, vol. 3, no. 3, pp. 339–347, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. D. Levine, “Apoptosis: implications for inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 6, no. 3, pp. 191–205, 2000. View at Google Scholar · View at Scopus
  6. R. B. Sartor, “Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis,” Nature Clinical Practice Gastroenterology and Hepatology, vol. 3, no. 7, pp. 390–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. G. Neuman, “Immune dysfunction in inflammatory bowel disease,” Translational Research, vol. 149, no. 4, pp. 173–186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. H. Wyllie, J. F. R. Kerr, and A. R. Currie, “Cell death: the significance of apoptosis,” International Review of Cytology, vol. 68, pp. 251–306, 1980. View at Google Scholar · View at Scopus
  9. D. Brenner and T. W. Mak, “Mitochondrial cell death effectors,” Current Opinion in Cell Biology, vol. 21, no. 6, pp. 871–877, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Özören and W. S. El-Deiry, “Cell surface death receptor signaling in normal and cancer cells,” Seminars in Cancer Biology, vol. 13, no. 2, pp. 135–147, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Dirisina, R. B. Katzman, T. Goretsky, E. Managlia, N. Mittal, D. B. Williams et al., “p53 and PUMA independently regulate apoptosis of intestinal epithelial cells in patients and mice with colitis,” Gastroenterology, vol. 141, no. 3, pp. 1036–1045, 2011. View at Publisher · View at Google Scholar
  12. L. J. Hofseth, S. Saito, S. P. Hussain et al., “Nitric oxide-induced cellular stress and p53 activation in chronic inflammation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 1, pp. 143–148, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. S. P. Hussain, L. J. Hofseth, and C. C. Harris, “Radical causes of cancer,” Nature Reviews Cancer, vol. 3, no. 4, pp. 276–285, 2003. View at Google Scholar · View at Scopus
  14. B. A. Lashner, W. M. Bauer, L. A. Rybicki, and J. R. Goldblum, “Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis,” The American Journal of Gastroenterology, vol. 98, no. 6, pp. 1423–1427, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Alkim, B. Savas, A. Ensari et al., “Expression of p53, VEGF, microvessel density, and cyclin-D1 in noncancerous tissue of inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 54, no. 9, pp. 1979–1984, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Jin, V. S. Kotakadi, L. Ying et al., “American ginseng suppresses inflammation and DNA damage associated with mouse colitis,” Carcinogenesis, vol. 29, no. 12, pp. 2351–2359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. V. S. Kotakadi, Y. Jin, A. B. Hofseth et al., “Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis,” Carcinogenesis, vol. 29, no. 9, pp. 1799–1806, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Bunz, P. M. Hwang, C. Torrance et al., “Disruption of p53 in human cancer cells alters the responses to therapeutic agents,” The Journal of Clinical Investigation, vol. 104, no. 3, pp. 263–269, 1999. View at Google Scholar · View at Scopus
  19. M. Andreeff, D. W. Goodrich, and A. B. Pardee, “Cell proliferation, differentiation, and apoptosis,” in Holland-Frei Cancer Medicine, R. C. Bast, D. W. Kufe, P. E. Pollock, R. R. Weicheelbaum, J. F. Holland, E. Frei et al., Eds., BC Decker, Ontario, Canada, 5th edition, 2000. View at Google Scholar
  20. M. B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig, “Participation of p53 protein in the cellular response to DNA damage,” Cancer Research, vol. 51, no. 23, part 1, pp. 6304–6311, 1991. View at Google Scholar · View at Scopus
  21. S. J. Kuerbitz, B. S. Plunkett, W. V. Walsh, and M. B. Kastan, “Wild-type p53 is a cell cycle checkpoint determinant following irradiation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 16, pp. 7491–7495, 1992. View at Google Scholar · View at Scopus
  22. A. R. Clarke, C. A. Purdie, D. J. Harrison et al., “Thymocyte apoptosis induced by p53-dependent and independent pathways,” Nature, vol. 362, no. 6423, pp. 849–852, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. S. W. Lowe, E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks, “p53 is required for radiation-induced apoptosis in mouse thymocytes,” Nature, vol. 362, no. 6423, pp. 847–849, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. M. S. Greenblatt, W. P. Bennett, M. Hollstein, and C. C. Harris, “Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis,” Cancer Research, vol. 54, no. 18, pp. 4855–4878, 1994. View at Google Scholar · View at Scopus
  25. V. A. Assinewe, B. R. Baum, D. Gagnon, and J. T. Arnason, “Phytochemistry of wild populations of Panax quinquefolius L. (North American ginseng),” Journal of Agricultural and Food Chemistry, vol. 51, no. 16, pp. 4549–4553, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. W. E. Court, “Ginseng: the history of an insignificant plant,” Pharmaceutical Historian, vol. 30, no. 3, pp. 38–44, 2000. View at Google Scholar · View at Scopus
  27. B. Li, C. Z. Wang, T. C. He, C. S. Yuan, and W. Du, “Antioxidants potentiate American ginseng-induced killing of colorectal cancer cells,” Cancer Letters, vol. 289, no. 1, pp. 62–70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Poudyal, P. Mai Le, T. Davis, A. B. Hofseth, A. Chumanevich, A. A. Chumanevich et al., “A Hexane fraction of American ginseng suppresses mouse colitis and associated colon cancer: anti-inflammatory and proapoptotic mechanisms,” Cancer Prevention Research, vol. 5, no. 4, pp. 685–696, 2012. View at Publisher · View at Google Scholar
  29. S. P. Hussain and C. C. Harris, “p53 biological network: at the crossroads of the cellular-stress response pathway and molecular carcinogenesis,” Journal of Nippon Medical School, vol. 73, no. 2, pp. 54–64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. J. Schetter, N. H. Heegaard, and C. C. Harris, “Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways,” Carcinogenesis, vol. 31, no. 1, Article ID bgp272, pp. 37–49, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. T. R. Skopek, H. L. Liber, B. W. Penman, and W. G. Thilly, “Isolation of a human lymphoblastoid line heterozygous at the thymidine kinase locus: possibility for a rapid human cell mutation assay,” Biochemical and Biophysical Research Communications, vol. 84, no. 2, pp. 411–416, 1978. View at Google Scholar · View at Scopus
  32. Y. Y. E. Chuang, Q. Chen, and H. L. Liber, “Radiation-induced mutations at the autosomal thymidine kinase locus are not elevated in p53-null cells,” Cancer Research, vol. 59, no. 13, pp. 3073–3076, 1999. View at Google Scholar · View at Scopus
  33. U. Schneider, H. U. Schwenk, and G. Bornkamm, “Characterization of EBV-genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma,” International Journal of Cancer, vol. 19, no. 5, pp. 621–626, 1977. View at Google Scholar · View at Scopus
  34. J. Cheng and M. Haas, “Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines,” Molecular and Cellular Biology, vol. 10, no. 10, pp. 5502–5509, 1990. View at Google Scholar · View at Scopus
  35. R. Laumann, M. Jucker, and H. Tesch, “Point mutations in the conserved regions of the p53 tumour suppressor gene do not account for the transforming process in the Jurkat acute lymphoblastic leukemia T-Cells,” Leukemia, vol. 6, no. 3, pp. 227–228, 1992. View at Google Scholar · View at Scopus
  36. X. Cui, Y. Jin, A. B. Hofseth et al., “Resveratrol suppresses colitis and colon cancer associated with colitis,” Cancer Prevention Research, vol. 3, no. 4, pp. 549–559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Reagan-Shaw, M. Nihal, and N. Ahmad, “Dose translation from animal to human studies revisited,” The FASEB Journal, vol. 22, no. 3, pp. 659–661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. G. N. Predy, V. Goel, R. Lovlin, A. Donner, L. Stitt, and T. K. Basu, “Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial,” Canadian Medical Association Journal, vol. 173, no. 9, pp. 1043–1048, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Vuksan, M. P. Stavro, J. L. Sievenpiper et al., “American ginseng improves glycemia in individuals with normal glucose tolerance: effect of dose and time escalation,” Journal of the American College of Nutrition, vol. 19, no. 6, pp. 738–744, 2000. View at Google Scholar · View at Scopus
  40. L. A. Dieleman, M. J. Palmen, H. Akol et al., “Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines,” Clinical and Experimental Immunology, vol. 114, no. 3, pp. 385–391, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. O. Morteau, S. G. Morham, R. Sellon et al., “Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2,” The Journal of Clinical Investigation, vol. 105, no. 4, pp. 469–478, 2000. View at Google Scholar · View at Scopus
  42. L. Ying, J. Marino, S. P. Hussain et al., “Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation,” Cancer Research, vol. 65, no. 20, pp. 9132–9136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Fiocchi, “Inflammatory bowel disease: etiology and pathogenesis,” Gastroenterology, vol. 115, no. 1, pp. 182–205, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. V. K. Wong, S. S. Cheung, T. Li et al., “Asian ginseng extract inhibits in vitro and in vivo growth of mouse lewis lung carcinoma via modulation of ERK-p53 and NF-κB signaling,” Journal of Cellular Biochemistry, vol. 111, no. 4, pp. 899–910, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. E. Kim, Y. H. Lee, J. H. Park, and S. K. Lee, “Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21(WAF1) in human hepatoma SK-HEP-1 cells,” European Journal of Cancer, vol. 35, no. 3, pp. 507–511, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. S. E. Kim, Y. H. Lee, J. H. Park, and S. K. Lee, “Ginsenoside-Rs3, a new diol-type ginseng saponin, selectively elevates protein levels of p53 and p21WAF1 leading to induction of apoptosis in SK-HEP-1 cells,” Anticancer Research, vol. 19, no. 1, pp. 487–491, 1999. View at Google Scholar · View at Scopus
  47. X. L. Yang, T. K. Guo, Y. H. Wang, Y. H. Huang, X. Liu, X. X. Wang et al., “Ginsenoside Rd attenuates the inflammatory response via modulating p38 and JNK signaling pathways in rats with TNBS-induced relapsing colitis,” International Immunopharmacology, vol. 12, no. 2, pp. 408–414, 2012. View at Publisher · View at Google Scholar
  48. E. H. Joh, I. A. Lee, I. H. Jung, and D. H. Kim, “Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation—the key step of inflammation,” Biochemical Pharmacology, vol. 82, no. 3, pp. 278–286, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Moon, S. J. Yu, H. S. Kim, and J. Sohn, “Induction of G1 cell cycle arrest and p2KIP1 increase by panaxydol isolated from Panax ginseng,” Biochemical Pharmacology, vol. 59, no. 9, pp. 1109–1116, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Wolf and V. Rotter, “Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 3, pp. 790–794, 1985. View at Google Scholar · View at Scopus
  51. Z. Yan, R. Yang, Y. Jiang et al., “Induction of apoptosis in human promyelocytic leukemia HL60 cells by panaxynol and panaxydol,” Molecules, vol. 16, no. 7, pp. 5561–5573, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. J. I. Kwon, G. Y. Kim, K. Y. Park, C. H. Ryu, and Y. H. Choi, “Induction of apoptosis by linoleic acid is associated with the modulation of Bcl-2 family and Fas/FasL system and activation of caspases in AGS human gastric adenocarcinoma cells,” Journal of Medicinal Food, vol. 11, no. 1, pp. 1–8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. R. S. Wong, “Apoptosis in cancer: from pathogenesis to treatment,” Journal of Experimental & Clinical Cancer Research, vol. 30, p. 87, 2011. View at Publisher · View at Google Scholar
  54. M. R. Kang, H. M. Kim, J. S. Kang et al., “Lipid-soluble ginseng extract induces apoptosis and G0/G1 cell cycle arrest in NCI-H460 human lung cancer cells,” Plant Foods for Human Nutrition, vol. 66, no. 2, pp. 101–106, 2011. View at Publisher · View at Google Scholar · View at Scopus